Biogen Inc. buy Royal Bank of Canada
Start price
26.06.24
/
50%
€208.90
Target price
26.06.25
€296.81
Performance (%)
-48.28%
End price
27.06.25
€108.05
Summary
This prediction ended on 27.06.25 with a price of €108.05. The BUY prediction by Royal_Bank_of_Canada for Biogen Inc. performed very badly with a performance of -48.28%. Royal_Bank_of_Canada has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 4.089% | 4.089% | -42.402% |
| iShares Core DAX® | 0.349% | 1.049% | 31.190% |
| iShares Nasdaq 100 | -0.123% | 2.919% | 13.472% |
| iShares Nikkei 225® | 4.212% | -0.666% | 5.130% |
| iShares S&P 500 | 0.479% | 3.318% | 9.358% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $317.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten